Healthcare & Life Sciences
Alumis Therapeutics
United Statesalumis.com
Alumis Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Alumis Therapeutics
Based in the United States, Alumis Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Alumis Therapeutics develops next-generation targeted therapies for immune-mediated diseases, leveraging a proprietary data analytics platform to support precision therapeutic development and advancing a late-stage portfolio including envudeucitinib.
Explore Alumis Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.